Team

WhatsApp Image 2025-03-30 at 11.19.46_5f4aab59
Noha Shalaby:

Noha Shalaby - Founder & CEO

Dr. Noha Shalaby (RPh, PhD) is a proud compounding pharmacist & entrepreneur. In 2012, Shalaby became the first internationally certified compounding pharmacist in the Middle East by global international bodies. Over the years, Shalaby had attended advanced and extended compounding trainings & courses in key markets like USA, Canada & Australia. These trainings span from simple Non-Sterile to High-Risk Sterile compounding. She went through in-depth trainings in key therapeutic areas that tackle hormonal imbalances in men and women through BHRT and critical therapy areas like peptides & pain management.Building on that, she built the foundations of modern personalised pharmaceutical compounding in the Middle East and served thousands of patients coming from around 20+ countries worldwide.

Travelling around the globe to learn about the different areas of pharmaceutical compounding, Shalaby was recognised for her efforts by international compounding bodies and was invited to speak about her experiences in the emerging markets in the USA in 2018 in the 1st World Congress of Compounding.

Shalaby is the only pharmacist member in Asia & Middle East in American Academy of Anti-Aging Medicine (A4M), and an active member of the American College of Apothecaries.

To Shalaby, pharmaceutical compounding is a personal mission. She believes it is the most elite profession within the practice of pharmacy. It is in her firm beliefs that pharmaceutical compounding, with its modern tools and techniques, can change people’s lives for good.


Passion towards compounding by Shalaby made her take the step towards founding Sweet Treat Pharmacy & Compounding Lab. Sweet Treat was established in the Philippines in 2018 to serve patients across Asia Pacific with the utmost standards of pharmaceutical compounding. With dedication and perseverance, Sweet Treat had kick-started its operations in Cairo, Egypt during COVID times to serve patients in Egypt, the Middle East and Africa. She believes that with passion, dedication and hard work, dreams can come true.

Today, Sweet Treat Pharmacy and Compounding Lab serves patients over the globe and supports realization of multiple & diverse business ventures and alliances that would support the health and well-being of thousands of patients daily.

Fab New Photo
Fabrienne Anne Dizon

Fabrienne Anne Dizon - Global Ph. Compounding Director

Fabrienne Anne P. Dizon, RPh is a distinguished pharmacist specializing in pharmaceutical compounding and clinical pharmacy. As the Globa Compounding Director and Chief Pharmacist at Sweet Treat Pharmacy and Compounding Lab, Inc., she leads advancements in personalized medicine and innovative pharmaceutical solutions.
 
Holding a Bachelor of Science in Pharmacy and a postgraduate specialization in Clinical Pharmacy, Fabrienne possesses a strong foundation in both pharmaceutical sciences and patient-centered care. She has also completed several specialized trainings in pharmaceutical compounding, further enhancing her expertise in formulation development, regulatory compliance, and optimizing individualized therapies to improve patient outcomes.
 
Beyond her leadership role, she is deeply committed to education and mentorship. She has trained numerous professionals in compounding pharmacy and has played a key role in establishing compounding pharmacies, expanding access to high-quality, customized medications.
 
With a passion for innovation and excellence, Fabrienne continues to elevate the standards of compounding pharmacy, positioning Sweet Treat Pharmacy and Compounding Lab, Inc. as a trusted provider of specialized pharmaceutical care both locally and G“Passion”lobal.
Alex New Photo
Alex Holodny

Alex Holodny - Global Business Development Director

Alex received his BA from Vassar College in New York, started his career with KPMG’s corporate finance team and subsequently worked for a number of family offices.

Alex’s professional experience brings the team grounding in corporate finance, private equity and business development. Most recently, Alex’s professional focus has been on various segments of the longevity industry including telemedicine, AI in pharma, pharmaceutical compounding and longevity real estate.

Alex is passionate about weightlifting, yoga and meditation and is currently an MBA candidate at the University of Chicago Booth School of Business.